1990 Annual Report

MARKETING SECTION

The Marketing Section continued its efforts to ensure that public and private pharmaceutical
reimbursement programs do not adversely affect revenues needed to finance research and development.
To accomplish this, the Section worked with staff of the Health Care Systems Division to maintain effective relations with private insurers and managed-care organizations as well as with federal Medicare
and Medicaid agencies, including the new Agency for Health Care Policy and Research. This new Agency
was created to conduct outcomes research and to develop and disseminate practice guidelines.
The Section continued to assist member companies in complying with the Prescription Drug
Marketing Act of 1987. A workshop on sample tracking and accountability was held, and a new system
for collecting information from physicians on samples is being tested. Section Committees also are monitoring initiatives within FDA and other groups that could lead
to new guidelines on educational and promotional activities.
The Marketing Section-which is composed of marketing and sales executives-is guided by a Steering Committee and has three standing committees: Marketing
Research; Marketing Practices; and Developing Health Care Markets.

1990-91 CHAIRMAN
Alan Steigrod
Glaxo Inc.

PMA STAFF LIAISON
Karen Williams
Vice President,
Health Care Systems

PMA BOARD LIAISON
Paul E. Freiman

MEDICAL SECTION
The Medical Section took a leading role in helping to update the FDA's Clinical Guidelines.
The Section also worked on clinical research problems of general interest, clinical study requirements
for product approvals and the medical aspects of the drug evaluation and approval process. In addition,
the Section focused on medical manpower and training problems and on the relationship of the pharmaceutical industry to professional societies.
4The Section-which is composed of physicians-has a number of committees. They are: Clinical Safety Surveillance; Clinical Trials/Clinical Pharmacology; Consultants to the Steering Committee; Drug Labeling, Advertising and Information; Special
xm nPopulations Issues; Education and Training; International Medical Affairs; Medical RelaStions; Nomination and Membership; and Program.

1990-91 CHAIRMAN
William R. Darrow, M.D., Ph.D.
Schering-Plough Corp.

PMA STAFF LIAISON PMA BOARD LIAISON
John C. Petricciani, M.D. Sheldon G. Gilgore, M.D.
Vice President, Medical and
Regulatory Affairs

23